Women's preferences for reporting of Down syndrome screening results

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 42, Issue 5, 2002, Pages 504-507

  Mulvey, Sheila ^a   Pham, Trang ^a   Tyzack, Katrina ^a   Wallace, Euan M ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DECISION MAKING; DELIVERY; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; OUTPATIENT DEPARTMENT; PATIENT ATTITUDE; PRENATAL CARE; PRENATAL SCREENING; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING TEST; SPONTANEOUS ABORTION;

EID: 0036854650     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0004-8666.2002.00504.x     Document Type: Article

References (15)

1. Nicolaides KH, Brizot ML, Snijders RJM. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy. Br J Obstet Gynaecol. 1994 Sep; 101 (9): 782-786.
2. Wald NJ, Kennard A, Hackshaw AK. First trimester serum screening for Down's syndrome. Prenat Diagn. 1995 Dec; 15 (13): 1227-1240.
3. Wald NJ, George L, Smith D, Densem JW, Peterson K. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group. Br J Obstet Gynaecol. 1996 May; 103 (5): 407-412.
4. Halliday JL, Watson LF, Lumley J, Danks DM, Sheffield LJ. New estimates of Down syndrome risks at chorionic villus sampling, amniocentesis and livebirth in women of advanced maternal age from a uniquely defined population. Prenatal Diagn. 1995 May; 15 (5): 455-465.
5. Kornman LH, Wortelboer MJ, Beekhuis JR, Morssink LP, Mantingh A. Women's opinions and the implications of first- versus second-trimester screening for fetal Down's syndrome. Prenat Diagn. 1997 Nov; 17 (11): 1011-1018.
6. Mulvey S, Wallace EM. Women's knowledge of and attitudes to first and second trimester screening for Down's syndrome. Br J Obstet Gynaecol. 2000 Oct; 107 (10); 1302-1305.
7. Snijders RJ, Sundberg K, Holzgreve W, Henry G. Nicolaides KH. Maternal age- and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol. 1999 Mar; 13 (3): 167-170.
8. Hook EB, Cross PK, Schreinemachers DM. Chromosomal abnormality rates at amniocentesis and live-born infants. JAMA. 1983 Apr 15; 249 (15): 2034-2038.
9. Spencer K. What is the true fetal loss rate in pregnancies affected by trisomy 21 and how does this influence whether first trimester detection rates are superior to those in the second trimester? Prenat Diagn. 2001 Sep; 21 (9): 788-789.
10. MacIntosh MCM, Wald NJ, Chard T, Hansen J, Mikkelsen M, Therkelsen AJ, Petersen GB, Lundsteen C. The selective miscarriage of Down syndrome from 10 weeks of pregnancy. Br J Obstet Gynaecol. 1996 Nov; 103 (11): 1172-1173.
11. Royal College of Obstetricians and Gynaecologists Report of the RCOG working party on biochemical markers and the detection of Down's syndrome. 1993. London: RCOG Press.
12. Michie S, Smith D, Marteau TM. Prenatal tests: How are women deciding? Prenat Diagn. 1999 Aug; 19 (8): 743-748.
13. Green JM. Serum screening for Down's syndrome: experiences of obstetricians in England and Wales. BMJ. 1994 Sep 24; 309 (6957): 769-772.
14. Mulvey S, Wallace EM. Levels of knowledge of Down syndrome and Down syndrome testing in Australian women. Aust N Z J Obstet Gynaecol. 2001 May; 41 (21): 167-169.
15. Sadler M. Serum screening for Down's syndrome: how much do health professionals know? Br J Obstet Gynaecol. 1997 Feb; 104 (2): 176-179.